Podcasts about learning objectives describe

Welcome to Episode 4 of the SciTech Critical Evaluation of Literature and AI Series: “Smarter Summaries, Better Decisions: AI Across Medical Affairs"Medical Affairs teams handle a flood of scientific data, so how can AI help turn complexity into clarity? Join experts from the MAPS Scientific & Technical Knowledge Domain to discover how AI tools evaluate evidence for diverse functions, from field teams to HEOR and publications.In this session, you'll learn practical strategies for creating concise, decision-ready summaries and explore why context and clinical relevance must guide every AI-driven workflow. If you want to leverage AI to evaluate evidence, podcast is for you!Learning Objectives:Describe how AI tools adapt evidence evaluation for different Medical Affairs functionsExplore how field medical, medical communications, publications, medical information, and HEOR teams can prompt the same data set differently to generate outputs tailored to their specific needs.Demonstrate strategies to create concise, decision-ready summaries using AILearn practical prompting and structuring techniques that convert complex scientific literature into clear, stakeholder-specific deliverables that support better strategic and scientific decisions.Explain why context and applicability are essential in AI-enabled evidence workflowsUnderstand how role-specific context, intended use, and decision impact must guide both the prompting and interpretation of AI-generated outputs.Hear more from the Scientific & Technical Knowledge Domain through their position paper: "Safeguarding Scientific Rigor in the Critical Evaluation of Literature"

This April 2026 Heart Rhythm Journal publication reports a sub-analysis of the CHAMPION-AF trial evaluating left atrial appendage closure (LAAC) versus oral anticoagulation in patients with atrial fibrillation who previously underwent catheter ablation. The analysis demonstrated that LAAC with the WATCHMAN FLX device provided comparable protection against stroke, systemic embolism, and cardiovascular death when compared with NOAC therapy, while also reducing long-term non-procedural bleeding events. These findings support consideration of LAAC as an alternative stroke prevention strategy in selected post-ablation AF patients through individualized, shared decision-making. Digital Education Committee Member Danesh Kella, MBBS, FHRS discusses this article from the Heart Rhythm Journal that preceded the Heart Rhythm 2026 Late-Breaking Clinical Trial. He is joined in the conversation by Jason T. Jacobson, MD, FHRS, Ammar M. Killu, MBBS, and Gregory M. Marcus, MD, FHRS.   Learning Objectives Describe the rationale for left atrial appendage closure as an alternative to chronic oral anticoagulation in patients with atrial fibrillation after catheter ablation. Review the efficacy and safety outcomes from the CHAMPION-AF sub-analysis comparing LAAC and NOAC therapy in post-ablation AF patients.  Discuss patient selection considerations and the role of shared decision-making when choosing stroke prevention strategies following AF ablation.    Podcast Contributors Danesh Kella, MBBS, FHRS Jason T. Jacobson, MD, FHRS Ammar M. Killu, MBBS Gregory M. Marcus, MD, FHRS    Host and Contributor Disclosure(s): J.T. Jacobson •Board/Advisory Committee Membership: Abbott Medical •Honoraria/Speaking/Teaching/Consulting: Zoll Medical Corporation, Vektor Medical, Inc. •Research: CardioFocus, Inc., Johnson and Johnson •Stocks, Privately Held: Atlas 5D D. Kella •Honoraria/Speaking/Teaching/Consulting: Zoll Medical Corporation, MBW Spectrum A. Killu •Board/Advisory Committee Membership: Boston Scientific •Honoraria/Speaking/Teaching/Consulting: AtriCure, Inc., Abbott, Biosense Webster, Inc., Siemans Healthineers •Research: Boston Scientific, Access Point Technologies G.M. Marcus •Honoraria/Speaking/Teaching/Consulting: InCarda Therapeutics •Research: NIH, PCORI, TRDRP •Stocks, Publicly Traded: InCarda Therapeutics  

This discussion reviews the late-breaking HRS 2026 study Total Fatal Adverse Events Following Atrial Fibrillation Ablation Reported in an FDA Mandatory Reporting System: A Matter of Concern? The TiFFANY Study, which examined fatal adverse event reports associated with atrial fibrillation ablation using data from the FDA MAUDE database. Faculty discuss the incidence and mechanisms of rare but serious complications across ablation technologies, including pulsed field ablation and thermal energy sources, and explore the implications for procedural safety, post-market surveillance, and clinical decision-making in AF ablation. Join host Melissa E. Middeldorp, MPH, PhD and her esteemed guests Christopher F. Liu, MD, FHRS and James Freeman, MD, MPH, Msci for this late-breaking coverage from Heart Rhythm 2026 in Chicago! Learning Objectives Describe the methodology and key findings of the TiFFANY study evaluating fatal adverse events following atrial fibrillation ablation. Compare reported safety signals and complication profiles among pulsed field ablation and traditional thermal ablation technologies. Assess the role and limitations of post-market adverse event databases in evaluating procedural safety and informing electrophysiology practice.  Podcast Contributors Melissa E. Middeldorp, MPH, PhD, FHRS Christopher F. Liu, MD, FHRS James Freeman, MD, MPH, Msci  Host and Contributor Disclosure(s): D.C. Raja Nothing to disclose. A. Deshmukh Honoraria/Speaking/Teaching/Consulting: GE Healthcare, Biotronik, Medtronic, Biosense Webster Research: AltaThera Pharmaceuticals P. Lim Nothing to disclose.  

Join Digital Education Committee member Jason T. Jacobson, MD, FHRS, and his guests John L. Sapp, Jr., MD, FHRS and Kyoko Soejima, MD for this conversation at Heart Rhythm 2026 in Chicago. This discussion reviews the late-breaking clinical trial Ventricular Intramyocardial Navigation and Tachycardia Ablation Guided by Electrograms (VINTAGE): First-in-Human Experience with a Novel Therapy for Refractory Ventricular Arrhythmia, presented at HRS 2026 in Chicago. Faculty discuss the novel VINTAGE technique, which enables catheter-based navigation and ablation within the myocardial wall to target deep intramural ventricular arrhythmia substrates that are often inaccessible with conventional endocardial or epicardial approaches. The conversation highlights the potential clinical impact of this first-in-human experience, including procedural feasibility, mechanistic innovation, and future implications for the treatment of patients with refractory ventricular tachycardia and complex ventricular arrhythmias.   Learning Objectives Describe the VINTAGE intramyocardial navigation approach and its proposed role in the treatment of refractory ventricular arrhythmias.  Evaluate the clinical challenges associated with mapping and ablating deep intramural ventricular tachycardia substrates using conventional techniques.  Assess the potential implications of first-in-human feasibility and safety findings for future ventricular arrhythmia ablation strategies.    Podcast Contributors Jason T. Jacobson, MD, FHRS John L. Sapp, Jr., MD, FHRS Kyoko Soejima, MD   Host and Contributor Disclosure(s): J. Jacobson • Honoraria/Speaking/Teaching/Consulting: Zoll Medical Corporation, Vektor Medical Inc. • Stocks, Privately Held: Atlas 5D • Research: CardioFocus, Inc. • Membership on Advisory Committees: Abbott Medical, Johnson and Johnson J. Sapp • Honoraria/Speaking/Teaching/Consulting: Medtronic, Varian Medical Systems, Biosense Webster • Research: Abbott Medical, Biosense Webster K. Soejima • Honoraria/Speaking/Consulting: Medtronic Japan, Boston Scientific Japan, Abbott Medical, Abbott Japan, Boehringer Ingelheim, Daiichi Sankyo 

Welcome to the third in this week's series of Lead episodes covering late breaking clinical trials from Heart Rhythm 2026 in Chicago. Join host Michael Lloyd, MD, FHRS, and his guests Christopher Kowalewski, MD and Karin Benali, MD, PhD for this discussion. This first-in-human, prospective study presented at Heart Rhythm 2026 evaluated noninvasive proton beam cardiac radioablation for patients with refractory ventricular tachycardia who had failed prior ablation and medical therapy. In a small, high-risk cohort, proton therapy was feasible and demonstrated substantial reductions in VT burden (approximately 80%) with no significant treatment-related toxicity observed during follow-up. These early findings highlight proton beam radioablation as a promising, highly targeted, noninvasive treatment option, though larger studies are needed to confirm long-term safety and durability.   Learning Objectives: Describe the principles of cardiac radioablation and the advantages of proton beam therapy compared with photon-based approaches for treating ventricular tachycardia.  Evaluate early feasibility, safety, and efficacy outcomes of proton beam therapy in patients with refractory ventricular tachycardia.  Assess the potential role of noninvasive cardiac radioablation in the treatment algorithm for patients with drug- and ablation-refractory ventricular tachycardia.    Podcast Contributors Michael S. Lloyd, MD, FHRS Christopher Kowalewski, MD Karin Benali, MD, PhD   Host and Contributor Disclosure(s): M. Lloyd •Honoraria/Speaking/Teaching/Consulting: Medtronic •Membership on Advisory Committees: Boston Scientific K. Bemali Nothing to disclose. D. Chew Nothing to disclose.

Welcome to the second episode this week in our triple header of late breaking clinical trials coverage from Heart Rhythm 2026 in Chicago. Host Christopher C Cheung, MD, MPH, FHRS is joined by Mihail G. Chelu, MD, PhD, FHRS and Derek Chew, MD, MS, FHRS for a conversation in Chicago. The LEAP2 trial, a first-in-human chronic feasibility study presented at Heart Rhythm 2026, evaluated a novel leadless pacemaker designed for conduction system pacing to more closely replicate physiologic cardiac activation. Early results from this small cohort demonstrated high implantation success, reliable device performance, and effective pacing of the heart's native conduction pathways through short-term follow-up. These findings highlight the potential of leadless conduction system pacing as an innovative alternative to traditional pacing strategies, pending further long-term data.   Learning Objectives Describe the principles and clinical rationale for conduction system pacing and how it differs from traditional right ventricular pacing.  Evaluate early safety and performance outcomes of novel leadless pacemaker systems designed for physiologic pacing.  Assess the potential clinical implications and future role of leadless conduction system pacing technologies in patients requiring permanent pacing.   Podcast Contributors Christopher C Cheung, MD, MPH, FHRS Mihail G. Chelu, MD, PhD, FHRS Derek Chew, MD, MS, FHRS   C. Cheung •Honoraria/Speaking/Teaching/Consulting: Medtronic, Biotronik, Biosense Webster, Abbott M. Chelu •Honoraria/Speaking/Teaching/Consulting: Impulse Dynamics, USA •Research: Abbott, Impulse Dynamics USA, VDI Technologies, PCORI, NIH/NHLBI D. Chew •Research: Canadian Institute of Health Research, Heart and Stroke Foundation of Canada

Join host Melissa Middeldorp and her guests Marco Perez and Kristie Coleman for this installment of The Lead! This multicenter randomized controlled trial evaluated whether smartwatch-based rhythm monitoring improves detection of previously undiagnosed atrial fibrillation (AF) in cardiology outpatients aged ≥65 years with elevated stroke risk. A total of 437 participants were randomized to either 6-month monitoring with an Apple Watch integrating photoplethysmography-based irregular rhythm detection and single-lead ECG confirmation, supported by a telemonitoring adjudication pathway, or to standard care. The primary endpoint of new AF occurred significantly more often in the intervention group than in controls (9.6% vs 2.3%; HR 4.40), with many cases asymptomatic and detected earlier through wearable monitoring. All diagnosed patients were initiated on anticoagulation, and major adverse cardiovascular events were similar between groups. Overall, the study demonstrates that prolonged smartwatch-based screening embedded within a clinical workflow substantially increases AF detection in a high-risk population, highlighting the feasibility of wearable-enabled case finding while underscoring ongoing questions regarding clinical outcomes and optimal implementation. Learning Objectives Describe the design and key findings of a randomized trial evaluating smartwatch-based screening for atrial fibrillation in older patients at elevated stroke risk. Discuss the clinical implications, limitations, and broader evidence context of wearable-enabled atrial fibrillation detection within contemporary screening strategies.   Article Authors Nicole J. van Steijn, Isabel S. Blommestijn, Sebastiaan Blok, Shari Pepplinkhuizen, Aernout Somsen, Reinoud E. Knops, Laura Breukel, Jan G.P. Tijssen, Igor I. Tulevski, Philip M. Croon, Michiel M. Winter Podcast Contributors Melissa E. Middeldorp, MPH, PhD Kristie Coleman, MPH, RN Marco Perez, MD Host and Contributor Disclosure(s): M. MiddeldorpNothing to disclose. K. Coleman •Honoraria/Speaking/Teaching/Consulting: Medtronic M. Perez •Honoraria/Teaching/Speaking/Consulting: Boston Scientific, Biontronik •Ownership/Partnership: QALY •Research: Apple, Inc.  

Join Dr. Salvatore Docimo for a discussion on endoscopic bariatrics, highlighting the benefits of Endoscopic Sleeve Gastroplasty (ESG) and how endoscopic sleeves can be used both as a primary weight loss procedure and as a bridge to future surgical intervention.Learning Objectives• Describe what endoscopic bariatrics is• Understand the benefits of Endoscopic Sleeve Gastroplasty (ESG)• How to utilize endoscopic sleeves as both a primary procedure and a bridge to additional surgeryAccreditationsPHYSICIANSACCMEUSF Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.USF Health designates this live activity for a maximum of 0.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Florida Board of MedicineUSF Health is an approved provider of continuing education for physicians through the Florida Board of Medicine. This activity has been reviewed and approved for up to 0.25 continuing education credits.Florida Board of Osteopathic MedicineUSF Health is an approved provider of continuing education for physicians through the Florida Board of Osteopathic Medicine. This activity has been reviewed and approved for up to 0.25 continuing education credits. Target Audience: Primary Care Providers, Ortho, Transplant, OBGYNRelease Date: April 16, 2026Expiration Date: April 16, 2027Relevant Financial RelationshipsAll individuals in a position to influence content have disclosed to USF Health any financial relationship with an ineligible organization. USF Health has reviewed and mitigated all relevant financial relationships related to the content of the activity. The relevant relationships are listed below. All individuals not listed have no relevant financial relationships.Salvatore Docimo, Jr. – Consultant: BD, Medtronic, Boston Scientific, Intuitive.Salvatore Docimo, Jr., DO, MBA: Director, Center for Abdominal Wall Surgery and Complex Hernia Repair, Tampa General HospitalAssociate Professor of Surgery, Division of Gastrointestinal Surgery, Department of SurgerySection Chief, Abdominal Wall SurgeryVice Chair of Quality, USF Department of Surgery Associate Director, Bariatric & Foregut Fellowship, USF Health Morsani College of Medicine Claim CME/CEU Credit for this episode here: https://cmetracker.net/USF/Publisher?page=pubOpen#/getCertificate/363296/qr Visit our Defining Medicine website, where you will find links to journal publications, clinical trials, podcasts and CMEs, physician profiles and more: https://www.tgh.org/defining-medicine.

In this discussion, Dr. Deep Chandh Raja, MBBS, MD, PhD, is joined by Dr. Chi Keong Ching, MBBS, FHRS, and Dr. Haris M. Haqqani, MD, PhD, FHRS, to review the growing empirical evidence supporting anatomically guided ablation strategies for idiopathic left ventricular (LV) summit ventricular arrhythmias. The panel highlights how integrating multimodality mapping with a nuanced understanding of the region's complex anatomy can improve procedural success and safety. They also emphasize the role of evolving techniques and shared clinical experience in refining outcomes for these challenging cases.   Learning Objectives Describe the anatomical challenges of the left ventricular (LV) summit and their implications for catheter ablation of idiopathic ventricular arrhythmias. Evaluate the role of multimodality mapping and anatomically guided strategies in improving procedural success and safety.  Identify emerging techniques and clinical insights that inform optimal ablation approaches for LV summit arrhythmias.    Article AuthorsTakumi Yamada and G. Neal Kay Podcast ContributorsDr. Deep Chandh Raja, MBBS, MD, PhD Dr. Chi Keong Ching, MBBS, FHRS Dr. Haris M. Haqqani, MD, PhD, FHRS   Host and Contributor Disclosure(s): D.C. Raja Nothing to disclose. C.K. Ching •Honoraria/Speaking/Teaching/Consulting: Abbott, Biotronik, Boston Scientific, Biosense Webster, Inc, Medtronic H. Haqqani •Honoraria/Speaking/Teaching/Consulting: Abbott Medical •Membership on Advisory Committees: Boston Scientific

In this episode, we welcome Kirollos Hanna, PharmD, BCPS, BCOP, a recognized leader in oncology pharmacy practice and research. Dr. Hanna shares insights into the evolving landscape of antibody-drug conjugates (ADCs) and the unique challenges they present in managing chemotherapy-induced nausea and vomiting (CINV).  As ADC use expands, oncology teams are observing new and sometimes underrecognized patterns of nausea and vomiting, particularly with HER2-directed therapies and delayed-phase symptoms that extend beyond the traditional monitoring window. This discussion highlights how these patterns differ from conventional chemotherapy and what that means for clinical practice.  Dr. Hanna also reviews emerging pharmacokinetic data and clinical trial evidence supporting the use of NK1 receptor antagonist–based antiemetic strategies. The conversation emphasizes practical, actionable approaches for optimizing supportive care, improving patient quality of life, and ensuring proactive symptom management within the medically integrated oncology team.  Learning Objectives:  Describe emerging patterns of chemotherapy-induced nausea and vomiting (CINV) associated with antibody–drug conjugates (ADCs), with emphasis on HER2-directed ADCs and delayed-phase nausea beyond day 5  Discuss pharmacokinetic and clinical trial evidence on NK1 receptor antagonist–based antiemetic strategies when optimizing CINV prevention for patients receiving ADC therapy.  This episode offers 0.5 CE credit hours to pharmacists and pharmacy technicians. Claim CE credit here. Guest: Kirollos Hanna, PharmD, BCPS, BCOP, Director of Pharmacy, Minnesota Oncology, Assistant Professor of Pharmacy, Mayo Clinic College of Medicine, Associate Editor, Journal of the Advanced Practitioner in Oncology (JADPRO)  Disclosures: Speaker: BeOne, BMS, Exelixis, Pfizer Consulting Fees: BeOne, BMS, Exelixis, Pfizer, Astrazeneca

Join Digital Education Committee member and podcast host Deep Chandh Raja, MBBS, MD, PhD, along with this week's guest contributors, Senthil Thambidorai, MD, FHRS  and Lee Karl Thien, MD, CCDS for this week's episode. This real-world registry study evaluated the safety, feasibility, and mid-term outcomes of pulsed field ablation (PFA) for cavotricuspid isthmus (CTI)–dependent atrial flutter. Acute bidirectional CTI block was achieved in nearly all patients, with a low complication rate and high freedom from recurrent flutter at mid-term follow-up. The findings suggest that PFA is an effective non-thermal alternative for typical atrial flutter ablation, though long-term durability and comparisons with conventional thermal energy sources require further investigation.    Learning Objectives Describe the procedural success rates and safety profile of pulsed field ablation for CTI-dependent atrial flutter. Compare pulsed field ablation with traditional thermal ablation strategies for typical atrial flutter. Discuss the role of emerging ablation technologies in the management of supraventricular tachyarrhythmias.    Article AuthorsJuan F. Rodriguez-Riascos, MD, Hema S. Vemulapalli, MBBS, Poojan Prajapati, MBBS, Padmapriya Muthu, MBBS, James Y. Kim, MD, Dan Sorajja, MD, Win-Kuang Shen, MD, Hicham El Masry, MD, Mayank Sardana, MBBS, MD, Arturo M. Valverde, MD, Thomas M. Munger, MD, and Komandoor Srivathsan, MD Podcast ContributorsSenthil Thambidorai, MD, FHRS Lee Karl Thien, MD, CCDS Deep Chandh Raja, MBBS, MD, PhD   All relevant financial relationships have been mitigated. Host and Contributor Disclosure(s): D. Raja Nothing to disclose.   S. Thambidorai Nothing to disclose.   L. K. Thien Nothing to disclose.   Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.

Join Digital Education Committee Vice-Chair and podcast host Tina Baykaner, MD, MPH, along with this week's guest contributors, Jackson J. Liang, DO and Edward P. Gerstenfeld, MD, MS, FHRS for this week's episode. This study evaluates the relationship between hospital ventricular tachycardia (VT) ablation volume and post-procedural complications, examining whether institutional procedural experience influences patient outcomes. The authors analyze complication rates across centers with varying VT ablation volumes to assess potential volume–outcome associations. Findings from this work provide important insights into procedural risk, quality metrics, and the potential impact of case volume on VT ablation safety.    Learning Objectives Describe the relationship between hospital VT ablation procedural volume and post-procedural complication rates. Identify patient, procedural, and institutional factors that may contribute to complications following ventricular tachycardia ablation. Discuss how volume–outcome findings can inform quality improvement initiatives, referral patterns, and procedural planning for VT ablation programs.    Article Authors Agam Bansal, Anirudh Nandan, Jakub Sroubek, Justin Lee, Koji Higuchi, Ayman Hussein, Shady Nakhla, Mina Chung, Niraj Varma, Walid Saliba, Mandeep Bhargava, Tyler Taigen, Mohamed Kanj, Oussama Wazni, and Pasquale Santangeli Podcast Contributors Tina Baykaner, MD, MPH Jackson J. Liang, DO Edward P. Gerstenfeld, MD, MS, FHRS   All relevant financial relationships have been mitigated. Host and Contributor Disclosure(s): T. Baykaner•Honoraria/Speaking/Consulting: Volta Medical, Medtronic, Pacemate, Johnson and Johnson, Abbot Medical, Boston Scientific •Research: NIH   E. Gerstenfeld •Speaking/Teaching/Consulting: Medtronic, Adiago Medical, Biosense Webster, Inc., Abbott, Boston Scientific, Abbott Medical, Varian Medical Systems •Research: Boston Scientific, Abbott Medical •Board Membership: American College of Cardiology Foundation   J. Liang •Speaking/Teaching/Consulting: Biotronik, Abbott, Bionsense Webster, Inc.   Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.

Join Digital Education Committee Member and podcast host Jason T. Jacobson, MD, FHRS, along with this week's guest contributors, Gaurav A. Upadhyay, MD, FHRS and Pugazhendhi Vijayaraman, MD, FHRS for this exciting conversation! This Heart Rhythm Journal article explores the electrophysiologic signatures that occur during left bundle branch pacing (LBBP) as lead position changes, with a focus on identifying "uninterrupted transition" patterns in recorded electrograms. The findings help clarify how subtle lead movement within the interventricular septum can alter electrogram morphology and capture behavior, improving clinicians' ability to confirm true conduction system engagement during implantation.  Read the article  Learning Objectives Describe the electrophysiologic basis of lead position–dependent electrogram changes observed during left bundle branch pacing. Differentiate uninterrupted transition electrogram patterns from other pacing capture transitions (e.g., septal capture vs LBB capture).  Apply electrogram transition findings to improve procedural decision-making for confirming optimal lead placement during LBBP implantation. Article AuthorsJiabo Shen, MD, Longfu Jiang, MD, Hao Wu, MD, Lu Zhang, MD, Hengdong Li, MD, Lifang Pan, MD Podcast ContributorsGaurav A. Upadhyay, MD, FHRS Pugazhendhi Vijayaraman, MD, FHRS Jason T. Jacobson, MD, FHRS Host and Contributor Disclosure(s): J. Jacobson Honoraria/Speaking/Teaching/Consulting: Zoll Medical Corporation, Vektor Medical Inc. Stocks, Privately Held: Atlas 5D Research: CardioFocus, Inc. Membership on Advisory Committees: Abbott Medical, Johnson and Johnson G. Upadhyay  Honoraria/Speaking/Teaching/Consulting: Boston Scientific, Abbott, Medtronic, Biontronik, Zoll Medical Corporation P. Vijayaraman   Honoraria/Speaking/Consulting: Medtronic, Boston Scientific, Biotronik, Abbott Medical, Abbott Research: Medtronic Fellowship Support: Medtronic   Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.  

Welcome to this week's episode of The Lead. Join HRS Digital Education Committee member and podcast host Danesh Kella, MBBS, FHRS as he welcomes his guests Rahul N Doshi, MD, FHRS and Robert D Schaller, DO, FHRS. They are discussing Mechanical Vacuum Aspiration and Debulking of Large Vegetations During Cardiac Implantable Electronic Device Extractions, which was published in the Journal of the American College of Cardiology in October 2025. This article describes the use of mechanical vacuum aspiration systems to debulk large intracardiac vegetations during cardiac implantable electronic device (CIED) extraction, aiming to reduce embolic risk and procedural complications. The authors highlight procedural techniques, patient selection, and safety considerations when combining aspiration with transvenous lead extraction. This approach represents an important adjunctive strategy for managing complex CIED infections with large vegetations.   Learning Objectives Describe the role of mechanical vacuum aspiration in the management of large vegetations during CIED extraction procedures. Identify patient selection criteria and procedural considerations for safely combining vegetation debulking with transvenous lead extraction. Recognize potential risks, benefits, and complications associated with aspiration-assisted extraction in patients with CIED infection.   Article for Discussion: https://www.jacc.org/doi/10.1016/j.jacc.2025.07.043   Article Authors Yury Malyshev, Marc A. Miller, Anelechi Anyanwu, George C. Shaw, Mouhannad Sadek, Seth Newman, Sakshum Chadha, Maryam Saleem, Nana Gegechkori, Abhishek Maan, Daniel Musikantow, Mohit Turagam, William Whang, Joshua Lampert, Jacob Koruth, Srinivas Dukkipati, Eric Neibart, and Vivek Y. Reddy Podcast Contributors Danesh Kella, MBBS, FHRS Rahul N Doshi, MD, FHRS Robert D Schaller, DO, FHRS Host and Contributor Disclosure(s): D. Kella Honoraria/Speaking/Teaching/Consulting: Zoll Medical Corporation, MBW Spectrum R. Doshi Honoraria/Speaking/Teaching/Consulting: Boston Scientific, Kestra, Inc., Abbott, Impulse Dynamics   R. Schaller   Honoraria/Speaking/Consulting: Medtronic, Boston Scientific, Philips, Cook Medical Research: Abbott Medical   Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.  

Join Digital Education Committee Member and podcast host Deep Chandh Raja, MBBS, MD, PhD , and his guests Georgios Leventopoulos, MD, and Muthiah Subramanian, MD, CCDS, CEPS-A, for this week's Lead episode. This Heart Rhythm article investigates the Bachmann bundle as a target for pacing by using retrograde electrical mapping and correlating findings with underlying myocardial microstructure. The piece provides detailed insights into how Bachmann bundle activation pathways relate to tissue architecture, with implications for optimizing physiologic pacing strategies. These findings may help refine pacing techniques that aim to better mimic natural conduction and improve clinical responses.   Learning Objectives Describe the anatomical and electrophysiologic characteristics of the Bachmann bundle and its role in atrial conduction. Explain how retrograde mapping and microstructural correlation can identify optimal pacing targets within the atrial conduction system. Evaluate the potential clinical implications of Bachmann bundle pacing for achieving more physiologic atrial activation.   Article AuthorsDaniel L. Lustgarten, MD, PhD, FHRS, Nicole Habel, MD, PhD, Margaret Infeld, MD, MS, Daniel Correa de Sa, MD, Robert Lobel, MD, Peter Spector, MD, FHRS, Nathaniel Thompson, MD, Joseph Winget, MD, Neal Duong, BME, Bo Ye, MD, PhD, Paul A. Iaizzo, PhD, Markus Meyer, MD, PhD Podcast Contributors Deep Chandh Raja, MBBS, MD, PhD Georgios Leventopoulos, MD Muthiah Subramanian, MD, CCDS, CEPS-A Article Being Discussed Host and Contributor Disclosure(s): G. Leventopolous Nothing to disclose. D.C. Raja Nothing to disclose. M. Subramanian •Nothing to disclose.  

Join Digital Education Committee Member and podcast host Deep Chandh Raja, MBBS, MD, PhD (Kauvery Hospital), and his guests Nitish Badhwar, MBBS, FHRS (Stanford University), and Yash Lokhandwala, MD, DM, FACC (Holy Family Hospital)  for this week's Lead episode. This state-of-the-art review synthesizes current knowledge on multifocal ectopic Purkinje-related premature contractions (MEPPC) syndrome, highlighting its genetic underpinnings, distinctive electrophysiologic features, and clinical presentation across age groups. The authors emphasize advances in diagnosis and management, including the role of targeted pharmacologic therapy and catheter ablation, while identifying ongoing gaps in evidence and priorities for future research in this rare but increasingly recognized arrhythmia syndrome.  Learning Objectives Describe the genetic, clinical, and electrophysiologic characteristics of MEPPC syndrome and how they distinguish it from other causes of frequent ventricular ectopy. Discuss current diagnostic and management strategies for MEPPC syndrome, including the roles of pharmacologic therapy and catheter ablation. Identify key knowledge gaps and future research directions highlighted in the review and their implications for clinical practice. Article AuthorsPaolo Basile, MD, Maria Cristina Carella, MD, Stefania Zaccaro, MD, Marco Maria Dicorato, MD, Luca Sgarra, MD, Yamna Khan, MD, Gianluca Pontone, MD, PhD, Giovanni Luzzi, MD, PhD, Vincenzo Ezio Santobuono, MD, PhD, Cinzia Forleo, MD, PhD, Marco Matteo Ciccone, MD, PhD, and Andrea Igoren Guaricci, MD, PhD Podcast Contributors Nitish Badhwar, MBBS, FHRS Yash Lokhandwala, MD, DM, FACC Deep Chandh Raja, MBBS, MD, PhD  Host and Contributor Disclosure(s): N. Badhward•Speaking/Teaching/Consulting: Abbott, Zoll Medical Corporation Y. Lokhandwala•Speaking/Teaching/Consulting/Authoring: Indian Pacing and Electrophysiology Journal D.C. Raja •Nothing to disclose. Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.  

In this episode, Robin Merttens is joined by Tim Hardcastle, CEO and Co-founder of INSTANDA, to reflect on what it takes to turn a contrarian vision into a global insurtech platform and what the next decade of innovation might look like. Tim left a senior role at Hiscox to build a no-code platform for insurers at a time when most said it couldn't be done. Ten years on, INSTANDA powers operations around the world and is gearing up for its next big leap. This conversation revisits the early sparks of that journey, including a memorable chat at the Royal Exchange, and dives into the personal and professional lessons Tim has gathered along the way. In this conversation, Tim shares: Why the earliest versions of INSTANDA were built despite zero market demand How a falling out with a boss became the unexpected catalyst for entrepreneurship The reality of scaling a tech company in insurance including a motorbike sale to make payroll Why belief, timing and architecture were crucial to gaining traction How humility shaped both leadership style and product design What it means to lead through survival, scale and reinvention His view on legacy, moonshot AI and the importance of letting go What's fuelling his passion ten years in and where the next decade might lead This one is part retrospective, part roadmap and full of insight for anyone thinking long-term about change in insurance. Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe the early challenges of launching a no-code insurance platform in a sceptical market. Explain how belief, architecture and timing contributed to INSTANDA's success and scalability. Define the role of humility in effective insurtech leadership and product design. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 382 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

Join host and HRS Digital Education Committee Member Melissa Middeldorp, MPH, PhD and her guests Rod Passman, MD, FHRS, and Emma Svenberg, MD, PhD, live at HRX 2025. In this episode, we explore the AMALFI Randomized Clinical Trial, which evaluated whether remote, wearable-based screening can effectively detect asymptomatic atrial fibrillation in high-risk adults. The discussion breaks down the study design, key findings, and implications for population-level AF screening strategies. It also examines how emerging digital health tools may integrate into routine cardiovascular prevention.    Learning Objectives Describe the design, patient population, and primary outcomes of the AMALFI Randomized Clinical Trial. Evaluate the effectiveness of remote wearable monitoring compared with usual care for detecting asymptomatic atrial fibrillation. Discuss the potential clinical and health-system implications of implementing large-scale remote AF screening in high-risk populations.   Article Authors Rohan Wijesurendra, DPhil, Guilherme Pessoa-Amorim, DPhil, Georgina Buck, MSc,Charlie Harper, DPhil, Richard Bulbulia, MD, Alison Offer, PhD, Nicholas R. Jones, DPhil, Christine A'Court, MA, Rijo Kurien, MSc, Karen Taylor, MSc, Barbara Casadei, DPhil, Louise Bowman, MD.   Podcast Contributors Melissa E. Middeldorp, MPH, PhD Rod S. Passman, MD, FHRS Emma Svennberg, MD, PhD   Article for Discussion  

In this episode, Robin Merttens sits down with Haris Khan and Arved Pohlabeln, co-founders of Novee, to unpack what's broken in specialty underwriting — and how AI is finally in a position to fix it. Having met as consultants at Deloitte, Haris and Arved kept encountering the same themes: overworked underwriters, inconsistent submissions, and transformation efforts that rarely made a real difference. That frustration turned into action. Today, they're building Novee — an AI assistant designed specifically for underwriters, combining insight generation with targeted automation. In this conversation, Haris and Arved share: Why underwriting processes remain complex, fragmented and hard to standardise What makes specialty submissions so variable — and why every case feels like an edge case How Novee delivers value in two ways: by surfacing better risk insights and automating manual tasks Why underwriters are embracing AI tools now — not resisting them What it takes to get live in weeks, not months, with meaningful value The real-world impact of extracting information from unstructured submissions How they raised £1.6 million in seed funding and what they're doing with it Why verticalised AI is outperforming generic solutions in insurance What it means to redesign underwriting interaction patterns — and why inbox to insight is the future The case for using AI before you fix your data, not after Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe the real-world challenges underwriters face when working with inconsistent, unstructured submissions. Define the concept of verticalised AI in the context of specialty underwriting and how it differs from generic AI solutions. List the specific ways Novee supports underwriters through both insight delivery and task automation. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 381 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

Join host and Digital Education Committee Member Sandeep A Saha, MD, MS, FHRS for this lively discussion with his colleagues Charles A. Henrikson, MD, MPH, FHRS and Arun R. Mahankali Sridhar, MBBS, MPH, FACC. About this Article: In patients with symptomatic premature ventricular complexes (PVCs) refractory to medical therapy, non-invasive low-level tragus stimulation of the auricular branch of the vagus nerve significantly reduced median PVC burden compared to sham stimulation (median reduction ~13.4% vs ~8.6%; P = 0.021). The findings suggest that autonomic neuromodulation via transcutaneous vagal stimulation may offer a novel adjunctive therapy for frequent PVCs, although further larger trials are needed to evaluate long-term outcomes. Learning Objectives Describe the rationale and mechanism by which transcutaneous vagus nerve stimulation (tVNS) may modulate autonomic tone and reduce premature ventricular contractions. Summarize the design, methods, and key outcomes of the NoVa-PVC randomized crossover trial evaluating tVNS for symptomatic PVC reduction. Evaluate the clinical implications, limitations, and potential future applications of noninvasive neuromodulation as a therapeutic approach for ventricular arrhythmias. Article Authors Stefanos Zafeiropoulos MD, MBA, Kristie Coleman MPH, RN, Jonathan Kogan,Dimitrios Varrias MD, Jonas Leavitt BS, Alexandra Bekiaridou MD, Theodoros Zanos PhD, Stavros Zanos PhD, MD, Stavros Stavrakis PhD, MD, Stavros Mountantonakis MD, MBA  Podcast Contributors Sandeep A Saha, MD, MS, FHRS Charles A. Henrikson, MD, MPH, FHRS Arun R. Mahankali Sridhar, MBBS, MPH, FACC  All relevant financial relationships have been mitigated. Host Disclosure(s): S. Saha •Speaking/Teaching/Consulting: Medtronic   ​Contributor Disclosure(s):    C. Henrikson •Honoraria/Speaking/Teaching/Consulting: American College of Cardiology A. Sridhar •Nothing to disclose.   Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.

Description Join host and HRS Digital Education Committee Chair Michael S. Lloyd, MD, FHRS and his guests Miguel A. Leal, MD, FHRS, and Jason T. Jacobson, MD, FHRS, live at HRX 2025. In this prospective series of 12 device-naïve patients (median LVEF ~30%), the authors attempted permanent implantation of a single-coil DF-4 ICD lead into the left bundle branch area (LBBA). They achieved successful implantation with adequate sensing and pacing in 75% of patients, and during short-term follow-up the lead and RV parameters remained stable; minor complications occurred in ~25% of patients (lead micro-dislodgment and septal perforations). The authors conclude that LBBA ICD lead implantation is feasible with current tools and acceptable short-term outcomes, but note the higher-than-expected minor complication rate and emphasize the need for dedicated toolkits, higher operator volume, and a procedural learning curve. Learning Objectives Describe the procedural feasibility, safety considerations, and short-term outcomes associated with left bundle branch area (LBBA) DF-4 defibrillator lead implantation. Identify key technical caveats and patient selection factors relevant to adopting this emerging pacing strategy in clinical practice. Article Information Permanent Left Budnle Branch Area DF-4 Debibrillator Lead Implantation Feasibility, Procedural Caveats, Safety, and Follow-Up Article Authors Anindya Ghosh, Chenni S. Sriram, Nibin Manu, Mullasari Ajit Sankaradas, Gaurav M. Upadhyay, Ulhas M. Pandurangi  Podcast Contributors Michael S. Lloyd, MD, FHRS  Jason T. Jacobson, MD, FHRS  Miguel A. Leal, MD, FHRS  All relevant financial relationships have been mitigated. Host Disclosure(s): M. Lloyd •Speaking/Teaching/Consulting: Medtronic, Arga Medtech, Circa Scientific   •Membership on Advisory Committees: Boston Scientific   ​Contributor Disclosure(s):    J. Jacobson •Stocks, Privately Held: Atlas 5D •Honoraria/Speaking/Teaching/Consulting: Zoll Medical Corporation, Vektor Medical, Inc. •Research: Abbott Medical, CardioFocus, Inc. M. Leal •Speaking/Teaching/Consulting: Medtronic   Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.

Description Join host and Digital Education Committee Member, Danesh Kella, MBBS, FHRS and his guests Ratika Parkash, MD, MS, FHRS and Prashanthan Sanders, MBBS, PhD, FHRS at HRX Live 2025 in Atlanta, for this exciting discussion. The PRAGUE-25 trial, published in JACC in 2025, compared catheter ablation with a program of lifestyle modification plus antiarrhythmic drugs in obese patients (BMI 30–40 kg/m2) with symptomatic atrial fibrillation. At 12 months, freedom from atrial fibrillation was significantly higher with ablation (73%) than with lifestyle modification + AADs (35%), despite the latter group achieving greater weight loss and metabolic improvement. The findings suggest that while aggressive risk-factor control improves overall health, catheter ablation remains more effective for rhythm control in this population.    Learning Objectives Describe the comparative effectiveness of catheter ablation versus lifestyle modification with antiarrhythmic drug therapy in obese patients with symptomatic atrial fibrillation. Discuss how weight reduction and risk-factor modification influence atrial fibrillation outcomes, while recognizing that catheter ablation provides superior rhythm control despite metabolic improvements achieved through lifestyle intervention.   Article Authors Pavel Osmancik, Tomas Roubicek, Stepan Havranek, Jan Chovancik, Veronika Bulkova, Dalibor Herman, Martin Matoulek, Vladimir Tuka, Ivan Ranic, Jana Hozmanova, Marek Hozman, Lucie Znojilova, Adam Latinak, Jan Pidhorodecky, Milan Dusik, Jan Simek, Otakar Jiravsky, Bogna Jiravska-Godula, Frantisek Lehar, Michal Cernosek, Zuzana Hejdukova, Hana Zelinkova, Jiri Jarkovsky, and Klara Benesova  Podcast Contributors Prashanthan Sanders, MBBS, PhD, FHRS Danesh Kella, MBBS, FHRS Ratika Parkash, MD, MS, FHRS    All relevant financial relationships have been mitigated. Host Disclosure(s): D. Kella •Speaking/Teaching/Consulting: Zoll Medical Corporation, MBW Spectrum  ​Contributor Disclosure(s):    R. Parkash •Research: Abbott, Medtronic, Novartis • Membership on Advisory Committees: Medtronic  P. Sanders •Membership on Advisory Committees: Medtronic PLC, Pacemate, CathRx, Boston Scientific, Abbott Medical • Research: Abbott, Becton Dickinson, Calyan Technologies, Ceryx Medical, Biosense Webster, CathRx, HelloAlfred, Medtronic, Inc., Abbott Medical  Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner): S. Sailor: No relevant financial relationships with ineligible companies to disclose.

Guest: Rebecca Smith, Ph. D, APRN, CNM Hosts: Danielle O'Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP Rebecca Smith provides a comprehensive overview of labor and delivery, including the stages of labor, assessment techniques, and monitoring practices. The episode also addresses potential complications and their management. Learning Objectives: Describe the stages, duration, and monitoring of labor and delivery. Compare and contrast complications that may arise during pregnancy and delivery. Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development

Guest: Casey Lawler, P.A.-C Hosts: Danielle O'Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP This episode provides an overview of gynecologic cancers, including cervical, ovarian, uterine, and vulvar cancers. Casey Lawler shares insights into the causes, risk factors, and clinical management of these conditions. Learning Objectives: Describe the major types of gynecologic cancers. Compare and contrast causes, risk factors, signs/symptoms, diagnostic methods, and treatment options.   Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development

In this episode, hosts Drs. Temara Hajjat and Jenn Lee talk to Dr. Jordan Whatley, Assitant Professor of Pediatrics at the Medical University of South Carolina and pediatric gastroenterologist at Shawn Jenkins Children's Hospital in Charleston, South Carolina. We discuss how multi-specialty clinics focusing on children with tracheostomy and ventilator dependence can improve clinical care.Learning Objectives:Describe the reasons children may require a tracheostomy and home mechanical ventilation.Explain multidisciplinary structure and purpose of an aerodigestive clinic in managing complex pediatric patients. Describe the gastroenterologist's role in evaluating and managing GERD, feeding intolerance, and nutritional needs in children with trach/vent dependence. Support the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

PURCHASE THIS PODCOURSE! If you are a therapist or counselor looking for continuing education, check out my NBCC Approved $5 Podcourses and other continuing education offerings.Plus, get your first Podcourse half off. In this Podcourse episode, I sit down with Dr. Timothy Davis, a psychologist who has spent his career working with what he calls “challenging boys.” He shares how his background, from academic research to volunteer firefighting, inspired a practical framework that helps parents manage meltdowns, build resilience, and strengthen their connection with their child. Together, we explore how therapists can support parents in creating effective Emergency Plans, identifying skill deficits in emotion regulation and executive functioning, and applying family systems principles to improve family dynamics. Our hope is that you'll walk away with fresh strategies you can integrate into your clinical work right away and you can also earn one NBCC continuing education contact hour by completing this Podcourse.

In this episode, Matthew is joined once again by Richard Hartley to reflect on a major milestone in Cytora's journey: its acquisition by US-based Applied Systems. But as Richard makes clear, this isn't the end of the road. It's a platform for scale. Listeners will hear how Cytora evolved from tackling political risk to transforming how risk flows through commercial insurance. Richard shares practical lessons from scaling into the US, explains why they rebuilt their platform around large language models and outlines why being agnostic to input but opinionated on risk output is a game changer. They also explore the cultural and technical alignment with Applied, the value of blending insurance expertise with external product thinking and what it really takes to make hard pivots, including knowing when to throw away what you've built. In this episode, Richard shares: Why Cytora rebuilt its platform around large language models — and what they threw away to make it work How “decision-ready risk” became a guiding principle for digitising insurance workflows What it really takes to expand into the US and earn client credibility market by market Why the idea of industry-wide standardisation is flawed — and how to work around it How to lead through uncertainty, scale a team and make tough product decisions Why insurance needs both deep domain knowledge and external perspective to innovate The underrated role of resilience in entrepreneurship — and what ballet and rugby taught him about pushing through If you like what you're hearing, please leave us a review on whichever platform you use or contact Richard Hartley or Matthew Grant on LinkedIn. Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how unstructured data enters the insurance value chain and the implications for underwriting workflows. Define the concept of “decision-ready risk” and its role in modernising commercial insurance operations. List the key factors that enabled Cytora's successful expansion into the US market. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 373 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

What will the specialty insurance market look like a decade from now? Will we still be talking about legacy systems and manual processes, or will the model itself have changed? In this panel discussion from InsTech's Outpace. Outprice. Outperform event, Robin Merttens leads a conversation with four senior experts on the future of the market and the forces that could reshape it. Featuring: Paul Carroll, Editor-in-Chief, Insurance Thought Leadership Toby Kovacs, Account Director, Google Cloud Andy Yeoman, CEO and Co-founder, Concirrus Tracie Thompson, Global Head of Strategic Clients, Cytora Together, they examine how emerging technologies, shifting client expectations and economic realities are pushing the market to rethink long-held assumptions about distribution, underwriting and talent. In this conversation, the panel explores: Whether brokers, underwriters and annual renewals will still have a role How capital and distribution are bypassing traditional intermediaries Why outsourcing is being redefined in the age of AI The impact of legacy behaviours, not just legacy systems How new models of work and regulation are influencing transformation Whether the protection gap is closing — or widening If you like what you're hearing, please leave us a review on whichever platform you use or contact Robin Merttens on LinkedIn.  Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how AI and automation are reshaping the boundaries of outsourcing in specialty insurance. List the key areas of the insurance value chain likely to undergo transformation in the next 10 years. Measure the potential impact of continuous underwriting and data-driven models on policy efficiency and pricing accuracy. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 369 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

Learning Objectives:- Describe the 4M's and recognize how to implement them in clinical practice- Distinguish between robust and frail individuals- Build inpatient and outpatient treatment plans based on mobility and frailty using the 4M'sSpeakers:- Mary Spivey, MD, CHI Health Internal Medicine- Kimberly Kudron, MPT, Physical Medicine and Rehabilitation, CHI Health- Priscilla James, ARNP, Adult Gerontology Acute Care Nurse Practitioner, Virginia Mason Franciscan Health- Michael Perlovsky, MD, Market Medical Director, Hospital Medicine, Mountain Region- Leah Wulfekoetter, MSN, MBA, RN, Nursing Director at Saint Elizabeth Medical Center, CHI Health

Why has claims innovation taken off in personal lines, but still lags behind in specialty? It's a question that many in the market have asked and in this episode, a panel of senior experts set out to answer it. Hosted by Andrew Pedler, Vice President at Reserv, this special discussion brings together three experienced voices from across the claims and consulting landscape: Chris Payne (Partner, EY), Andy Stevenson (Consultant Director, PwC), and Patrick Hayward (Claims Lead, Altus Consulting). Together, they examine why some of the biggest efficiency gains in motor and home claims haven't yet translated into specialty and what needs to change to unlock that value. In this conversation, the panel explores: Where personal lines have succeeded: distribution, automation,and data enrichment Why claims in specialty remain complex, fragmented and harder to automate The structural and cultural barriers to innovation including litigation risk and lack of direct customer engagement How changing expectations and regulatory pressures are creating momentum for transformation What a “claims workbench” might look like and how it mirrors trends in underwriting The panel's insight is clear: meaningful claims transformation in specialty is less about chasing point solutions and more about rethinking the role of claims within the wider enterprise from managing portfolios to improving capital efficiency. Whether you're trying to improve claims operations, justify technology investment, or just understand what's actually happening in the market, this is an honest and thought-provoking discussion with people who know the space inside out. If you like what you're hearing, please leave us a review on whichever platform you use or contact Matthew Grant on LinkedIn. Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe the key differences between personal lines and specialty claims processes, including complexity, litigation exposure, and stakeholder roles List the technological advancements successfully implemented in personal lines claims and assess their relevance to specialty markets Measure the impact of improved data ingestion and automation on claims processing efficiency and decision-making If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 363 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

DescriptionListen in as DESIGN:ED features architect Peter Ruggiero of HOK discussing key principles in contemporary airport design, emphasizing passenger experience, spatial transparency, adaptability, and sustainability. He highlights the importance of designing for change, citing projects like LaGuardia, O'Hare, and the Dulles expansion. Ruggiero reflects on his design philosophy, advocating for functional, flexible, and civic-minded architecture that responds to evolving travel demands. He also addresses material authenticity, clutter reduction, and the role of infrastructure in shaping public spaces. The discussion concludes with insights into his career journey and aspirations to enhance infrastructure design in future projects.Learning Objectives:Describe key principles of passenger-focused airport design, including transparency, flexibility, and spatial fluidity.Analyze the impact of evolving air travel demands on airport architecture and long-term planning.Evaluate the role of material selection, environmental considerations, and visual clarity in enhancing airport user experience.Examine how civic identity and infrastructure design intersect in the creation of modern transportation hubs.Credits: 1.0 AIA LU/ElectiveSpeaker:   Peter Ruggiero

What happens when one of the world's largest brokers and a digital-first underwriting platform team up to rethink risk trading? In this episode, Robin Merttens is joined by Sasa Brcerevic, Head of Portfolio and Delegated Strategy at Aon, and Ed Howkins, Chief Growth Officer at Artificial Labs. Together, they explore the evolving dynamics of wholesale broking, why now is the moment to digitise trading relationships and how insurers can stay competitive in a rapidly transforming landscape. The conversation offers a timely lens on the market-wide shift toward digital trading – not as a future ambition, but as an active and necessary response to competitive pressure. From the rise of underwriting-as-a-service to brokers leading platform innovation, this episode unpacks what insurers and brokers should be doing now to stay relevant. Key Talking Points Digitising the broker–underwriter interface: why transaction execution, not just placement admin, is the next frontier Strategic momentum: how digitisation moved from side project to boardroom priority across carriers and brokers Competitive catalysts: why fast movers are already capturing flow and shaping future adoption curves Platforms not portals: how Artificial is helping brokers remove friction while giving carriers underwriting optionality A new breed of carrier: exploring the shift from balance sheet-first models to digital risk transformation The data dividend: why data-rich submissions are changing how insurers allocate capital and differentiate themselves Incremental innovation: what makes today's efforts different from past false starts and what good adoption looks like Reimagining broking: how Aon is investing in technology to build its future operating model Sustainable advantage: why the biggest long-term gains lie in improving service, not just margin Time to jump in: why delaying digitisation could leave carriers and brokers on the outside looking in If you like what you're hearing, please leave us a review on whichever platform you use or contact Robin Merttens on LinkedIn. You can also contact Ed Howkins and Sasa Brcerevic on LinkedIn to start a conversation! Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how digitising wholesale broking can improve transactional efficiency and reduce operational friction. List the key challenges and opportunities in modernising risk trading processes between brokers and carriers. Explain how intentional digital adoption differs from previous waves of insurance market innovation. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 355 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

What if underwriters could instantly triage submissions and reduce time spent on repetitive admin, without changing how they work? Matthew Grant speaks with Matt McGrillis, Co-founder and Chief Product Officer at Send, to explore how the company's underwriting workbench is embedding AI into core workflows to help underwriters write more business, more profitably. Now on its third feature with InsTech, Send has evolved from an early-stage start-up to one of the UK's leading underwriting platforms. Matt shares how Send's latest innovations including agent workflows and AI-powered triage, are making decision-making faster all while running quietly behind the scenes. Key Talking Points How Send is digitising complex underwriting workflows to reduce friction and increase speed. How agent workflows are breaking down underwriting into manageable AI-driven tasks. Send's triage tools helping underwriters prioritise high-value business in real-time. Why GenAI is less about disruption and more about quiet, seamless transformation. How Send balances “build v buy” to offer agility without sacrificing functionality. Why clients working with Send are seeing faster quote turnaround and improved broker response. The importance of automating the “boring bits” so underwriters can focus on value. Matt's prediction on why AI agents and not flashy features will drive the next wave of adoption. If you like what you're hearing, please leave us a review on whichever platform you use or contact Matthew Grant on LinkedIn. You can also contact Matt McGrillis on LinkedIn to start a conversation! Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how AI agents are transforming underwriting workflows by automating repetitive tasks and enabling faster decision-making. Specify the types of underwriting tasks best suited for AI agents and automation. Identify key challenges insurers face when adopting AI tools and how Send supports clients through that transformation. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 353 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

Attracting and retaining talent in the London Market is an evolving concern, with the PwC CEO Survey revealing that 93% of respondents either recognise the need to change or are already adapting their strategies to address it. Let's discuss how! In this special podcast episode done in partnership with PwC, we invited Anna Craston, Senior Manager, to host a panel discussion to explore the critical trends shaping talent management in the London insurance market.  She's joined by fellow PwC colleague Simone Ritson, Phoebe Thomas from CFC, Jacinta Chiang from WTW and Alfie Holt from Marco Capital to share their firsthand experiences and insights. Together, they discuss how companies can build inclusive cultures, the shifting expectations of new talent and what organisations must do to stay competitive in a rapidly evolving landscape. This episode dives deep into why attracting diverse talent is just the beginning and why inclusion, development and purpose are the real keys to retention. Key talking points: Understand why changing employee expectations are reshaping the London insurance market. Learn how AI, automation, and technology are driving new workforce capabilities. Explore the historic challenges in attracting diverse talent to the London market — and how that's starting to change. Examine the impact of culture, career growth, and leadership development on employee retention. Discover the importance of outreach programs to schools and universities in broadening insurance career awareness. Hear why inclusion, not just diversity, is critical for long-term workforce engagement. See how mentorship, reverse mentoring, and visible career pathways can support retention. Get practical ideas for fostering inclusion, from flexible working to cultural days and accessible networking events. For more information, you can read PwC's Transforming the London Market report.  Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe the current challenges and evolving expectations around attracting and retaining talent in the London market. Explain how diversity and inclusion initiatives can move from hiring strategies to meaningful cultural change that fosters retention. Identify the most effective strategies companies can use to make the London insurance market more appealing to diverse, next-generation talent. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 351 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

What does it take to fundamentally rethink how specialty insurance is traded, structured and scaled? In this episode, Robin Merttens is joined by Jeff Radke, co-founder and CEO of Accelerant, for a deep dive into the mechanics of a rapidly growing risk exchange that's quietly reshaping the MGA and MGU landscape. It has been three years since Jeff joined us on the InsTech podcast, and even Accelerant has radically evolved as a business. This isn't, however, just another technology story. Jeff shares frank insights on building trust in a data-driven ecosystem, how Accelerant has used AI to make tangible portfolio improvements and why he believes platform-based risk trading will become the dominant model for specialty lines. Unlike many other discussions about AI in insurance, this episode focuses on what's already working – from subrogation improvements to portfolio optimisation. There's also a broader message here: about stepping back to see how much the market has changed and why the next evolution may already be underway… Key Talking Points Building a global risk exchange – how Accelerant connects specialty MGAs and MGUs with capacity through a single, scalable platform The value of long-term partnerships – why Accelerant provides five-year capacity commitments and expects transparency in return From niche to global – supporting 200+ underwriting teams across 20 countries and over 225 specialty products Applying AI where it matters – reducing loss ratios and boosting subrogation with machine learning and large language models Cost leadership in a softening market – why expense ratio advantage trumps rate cycles in SME and specialty risks Looking ahead – how AI is reshaping roles, workflows and the entire insurance value chain The rise of risk exchanges – why specialty insurance is following the same path as bonds, mortgages and equities Staying ahead – why Accelerant is focused on evolution, not just competition If you like what you're hearing, please leave us a review on whichever platform you use or contact Robin Merttens on LinkedIn. You can also contact Jeff Radke on LinkedIn to start a conversation! Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how a modern risk exchange connects specialty underwriters with capital providers. Identify the signs of systemic evolution in the insurance industry that indicate a shift toward platform-based models. Define the concept of a two-sided risk exchange and its advantages over traditional capacity models. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 348 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

From our Exponential Risk breakout session, to joining us on InsTech podcast - this week we are spotlighting Neena Saith's valuable discussion on the science of resilience.  Resilience is a familiar term in insurance, often associated with mitigating risk and protecting against natural disasters. But what about resilience at a personal level? How can individuals in high-pressure roles manage stress effectively and maintain their well-being? In this episode, Matthew Grant brings back Neena Saith, a former colleague and catastrophe risk analyst turned stress and resilience specialist, about the importance of managing personal stress in the workplace. Neena shares her journey from catastrophe modelling to working with individuals and organisations to help them recognise, understand and address stress. Together, they explore the physical and psychological impacts of stress, how organisations can create a healthier work culture and practical techniques for managing stress in high-pressure environments. Further resources connected to the conversation:  Anxiety Rx by Dr. Russell Kennedy – exploring the mind-body connection in managing anxiety When the Body Says No by Dr. Gabor Maté – understanding the link between stress, emotions and physical health Neena's website: www.neenashealing.com – for coaching, group programs and corporate workshops How to Meet Yourself by Dr Nicole LePera - an interactive workbook designed to help every reader uncover their authentic self. Connect with Neena on LinkedIn: Neena Saith Key Talking Points The missing conversation in insurance – why workplace stress and personal resilience matter just as much as risk modeling Recognising stress cycles – understanding how the body responds to stress and how to complete the stress cycle for recovery Mind-body connection – how unresolved stress manifests physically and why mental and physical health cannot be treated separately Building awareness – learning to recognize personal stress triggers and early warning signs before they escalate Practical techniques – breathing exercises, movement, and micro-breaks to reduce stress and improve resilience Organisational responsibility – how companies and managers can support employees by fostering open conversations about stress Personal responsibility – setting boundaries, managing workload, and creating habits that support long-term resilience Beyond the workplace – the impact of work-related stress on personal relationships and how to navigate it If you like what you're hearing, please leave us a review on whichever platform you use or contact Matthew Grant on LinkedIn. You can also contact Neena Saith on LinkedIn to start a conversation! Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how stress affects both the mind and body and why resilience is essential in high-pressure environments Explain the concept of the stress cycle and the importance of completing it for long-term well-being List practical techniques for reducing stress in daily work life, including breathing exercises and movement strategies If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 347 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

The automotive industry is undergoing a transformation—electrification, changing ownership models and evolving customer expectations are reshaping the market. But how does insurance fit into this shift?  In this episode, Robin Merttens speaks with Nimeshh Patel, CEO of Wrisk, about how the company is helping major automotive brands embed insurance seamlessly into the car-buying journey. With a customer-first digital experience, Wrisk enables instant, hassle-free insurance at the point of sale, eliminating outdated manual processes.  The discussion also covers Wrisk's international expansion, its Series B fundraising and why the company focuses on collaboration rather than disruption in the insurance ecosystem. Key Talking Points Embedded insurance at the point of sale – how Wrisk makes car insurance frictionless for customers Why  Original Equipment Manufacturer (OEMs) care about insurance – supporting after-sales revenue, finance uptake and customer retention Scaling success with global automotive brands – from BMW to Mercedes-Benz, how Wrisk is powering insurance for top manufacturers The power of quiet ego – why Wrisk has focused on collaboration rather than disruption Expanding beyond the UK – launching a European MGA and the roadmap for international growth The Series B strategy – raising funds to scale technology, data capabilities and global operations The future of automotive insurance – could Wrisk eventually take on risk itself and build OEM-backed captives? If you like what you're hearing, please leave us a review on whichever platform you use or contact Robin Merttens on LinkedIn. You can also contact Nimeshh Patel on LinkedIn to start a conversation! Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how embedded insurance enhances the vehicle purchasing experience by integrating seamless coverage at the point of sale. Explain why collaboration between insurers and OEMs is critical to the success of embedded insurance models. Define the role of a managing general agent (MGA) in enabling scalable, brand-aligned insurance solutions for automotive manufacturers. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 345 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

Do you find yourself saying: “Hey, what's the big idea with that newfangled whole blood in the refrigerator next to the trauma bay?”  Like using whole blood but not sure why?  Don't like using whole blood but not sure why? Join us for a 30 minute power session in whole blood where we try to get you the information you need to know! Hosts: - Michael Cobler-Lichter, MD, PGY4/R2: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @mdcobler (X/twitter) - Eva Urrechaga, MD, PGY-8, Vascular Surgery Fellow University of Pennsylvania Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center General Surgery Residency @urrechisme (X/twitter) - Eugenia Kwon, MD, Trauma/Surgical Critical Care Attending: Loma Linda University  Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center Trauma/CC Fellowship - Jonathan Meizoso, MD, MSPH Assistant Professor of Surgery, 6 years in practice University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @jpmeizoso (twitter) Learning Objectives: - Describe the proposed benefits of whole blood resuscitation in trauma -  Identify current problems with synthesizing the existing literature on whole blood resuscitation in trauma - Propose needed areas for future research regarding whole blood resuscitation in trauma Quick Hits: 1. There is significant heterogeneity in study design across whole blood resuscitation studies, complicating comparison 2.  There is likely a mortality benefit to whole blood resuscitation in trauma, however this is likely dependent on the specific population 3. Future research directions should focus on prospective randomized work to try and better quantify the exact benefit of whole blood, and determine in which populations this benefit is actually realized References 1.     Hazelton JP, Ssentongo AE, Oh JS, Ssentongo P, Seamon MJ, Byrne JP, Armento IG, Jenkins DH, Braverman MA, Mentzer C, Leonard GC, Perea LL, Docherty CK, Dunn JA, Smoot B, Martin MJ, Badiee J, Luis AJ, Murray JL, Noorbakhsh MR, Babowice JE, Mains C, Madayag RM, Kaafarani HMA, Mokhtari AK, Moore SA, Madden K, Tanner A 2nd, Redmond D, Millia DJ, Brandolino A, Nguyen U, Chinchilli V, Armen SB, Porter JM. Use of Cold-Stored Whole Blood is Associated With Improved Mortality in Hemostatic Resuscitation of Major Bleeding: A Multicenter Study. Ann Surg. 2022 Oct 1;276(4):579-588. doi: 10.1097/SLA.0000000000005603. Epub 2022 Jul 18. PMID: 35848743. https://pubmed.ncbi.nlm.nih.gov/35848743/ 2.     Sperry JL, Cotton BA, Luther JF, Cannon JW, Schreiber MA, Moore EE, Namias N, Minei JP, Wisniewski SR, Guyette FX; Shock, Whole Blood, and Assessment of Traumatic Brain Injury (SWAT) Study Group. Whole Blood Resuscitation and Association with Survival in Injured Patients with an Elevated Probability of Mortality. J Am Coll Surg. 2023 Aug 1;237(2):206-219. doi: 10.1097/XCS.0000000000000708. Epub 2023 Apr 11. PMID: 37039365; PMCID: PMC10344433. https://pubmed.ncbi.nlm.nih.gov/37039365/ 3.     Meizoso JP, Cotton BA, Lawless RA, et al. Whole blood resuscitation for injured patients requiring transfusion: A systematic review, meta-analysis, and practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2024;97(3):460-470. doi:10.1097/TA.0000000000004327 https://pubmed.ncbi.nlm.nih.gov/38531812/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Satellite imagery is revolutionising the way insurers assess risk, track disasters and provide coverage. In this episode, Matthew Grant speaks with Berend de Jong, Global Insurance & Finance Lead at Planet Labs, about how high-resolution satellite imagery and geospatial data are reshaping the insurance industry. With a fleet of over 200 satellites capturing daily images of the Earth's surface, Planet Labs enables insurers to enhance flood and wildfire risk modeling, parametric insurance solutions and pre/post-loss assessments. The conversation explores real-world applications, including how instant satellite imaging played a key role in analysing the Los Angeles wildfires and German floods, and how parametric insurance providers like Floodbase leverage satellite data to develop innovative flood coverage solutions. Key Talking Points From consulting to satellites – Berend's career journey How Planet Labs' 200+ satellites capture daily Earth imagery The power of high-resolution imaging – down to 30-40 cm Tasking satellites on demand – costs, speed, and accessibility Optical vs. SAR satellites – when to use each technology Los Angeles wildfires case study – tracking fire progression in real time German floods case study – distinguishing between river and rain-driven floods Parametric insurance in action – partnerships with AXA, Swiss Re, and FloodBase Underwriting & claims insights – using satellite data for smarter decisions The future of satellite data – affordability, accessibility, and evolving use cases If you like what you're hearing, please leave us a review on whichever platform you use or contact Matthew Grant on LinkedIn. You can also contact Berend de Jong on LinkedIn to start a conversation! Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how high-resolution satellite imagery supports risk assessment, underwriting, and claims management in insurance. List the key differences between optical satellites, SAR (Synthetic Aperture Radar) and passive microwave technology in data collection. Identify the real-world applications of satellite data through case studies, including Los Angeles wildfires and German floods. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 340 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

How is generative AI changing the way insurers work—and think? In this episode, Matthew Grant sits down with Bob Pick, EVP Chief Information Officer at Tokio Marine North American Services and Group Deputy Chief Information Technology Officer for Tokio Marine Group, to explore the real-world impact of generative AI in the insurance industry. From streamlining underwriting decisions to detecting fraud and automating operational processes, Bob explains how Tokio Marine is using AI to address both everyday challenges and complex, global demands. Balancing innovation with responsibility, the conversation sheds light on what AI can—and can't—do for insurers today. If you've ever wondered how generative AI works in practice, or what it means for the future of insurance, this episode offers clear and thought-provoking insights. Key Talking Points: The evolution of generative AI – from revolutionary tech to practical applications Classic AI vs. generative AI – understanding the difference Advisory tools like Microsoft Copilot – where they fit into the workflow Case studies from Tokio Marine – submission analysis and claims fraud detection Development tools – automating back-end processes with generative AI Risk management – balancing innovation with safeguarding data and compliance Tools of the trade – Microsoft Copilot, Grok, and other favourites Looking ahead – evolution or revolution in the next 1-3 years If you like what you're hearing, please leave us a review on whichever platform you use or contact Matthew Grant on LinkedIn. You can also contact Bob Pick on LinkedIn to start a conversation! Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how generative AI is transforming key processes in the insurance industry, such as underwriting and fraud detection. List the practical applications of generative AI discussed in the episode, including submission analysis, backend automation and global translation. Specify the differences between classic AI and generative AI, and their respective roles in insurance. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 339 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.  

In this Nursing World Shared Practice Forum podcast, Dr. Felesia Bowen, president-elect of the National Association of Pediatric Nurse Practitioners (NAPNAP), discusses the evolving role of nurse practitioners (NPs) in healthcare, and emphasizes the importance of NPs in health promotion and policy. She highlights the need for a national standardized scope of practice for NPs and advocates for increased diversity in the nursing workforce to address health and educational disparities. LEARNING OBJECTIVES - Describe the nurse practitioner's role within healthcare - Explain how current legislative and regulatory issues in the United States impact the nurse practitioner role - Discuss NAPNAP's plan to support health equity and expand global partnerships - Describe ways to diversify and support the nursing workforce to reduce health disparities AUTHORS Felesia Bowen, PhD, DNP, PPCNP-BC, FADLN, FAAN President-elect of NAPNAP, 2024-2027 Professor and Associate Dean for Access and Engagement University of Alabama at Birmingham Julia McSweeney, MSN, RN, CPNP Senior Director of Advanced Nursing Practice Boston Children's Hospital DATE January 20, 2025. TRANSCRIPT https://cdn.bfldr.com/D6LGWP8S/as/ksm5qr297mrv3j8fkm7x6mtj/011624_NWSP_Bowen_The_Role_of_Nurse_Practitioners_in_Healthcare_and_Policy Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user.For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu CITATION Bowen FR, Marcley S, DeGrazia M, McSweeney JE. The Role of Nurse Practitioners in Healthcare and Policy 01/2025. OPENPediatrics. https://soundcloud.com/openpediatrics/the-role-of-nurse-practitioners-in-healthcare-and-policy-by-f-bowen-openpediatrics.

This week on the InsTech Podcast, Robin Merttens speaks with Martin Olley, Head of North America and APAC for AdvantageGo, and Laurence Trigwell, Head of Strategy and Chief Revenue Officer at Insurants, about how technology is transforming the commercial insurance and reinsurance landscape. Martin and Laurence explore how their respective platforms are addressing key challenges in the industry, from intelligent document processing to streamlining underwriting and policy administration. They discuss the demand for innovation, the role of AI in improving efficiency and how their recent partnership is creating seamless solutions for insurers through an integrated ecosystem. Key talking points: The shift from exploration to execution: Insurers are moving beyond AI experimentation to apply practical, value-adding solutions. Intelligent document processing: Unlocking valuable data from submissions, loss runs and slips to streamline risk operations. Ecosystem partnerships: How collaborations like AdvantageGo and Insurants deliver end-to-end solutions for clients, enhancing operational efficiency. Quick wins in tech adoption: Agile approaches, like delivering results within nine weeks, build confidence and improve adoption. Orchestrating AI and machine learning: Combining multiple technologies to optimize accuracy and decision-making. Confidence in today's technology: Solutions are ready to deliver measurable ROI, enabling insurers to act now. If you like what you're hearing, please leave us a review on whichever platform you use or contact Matthew Grant on LinkedIn. Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe the role of AI and intelligent document processing in streamlining underwriting and risk operations. Define the concept of ecosystem partnerships and their impact on delivering integrated insurance solutions. List the key technologies, including AI, OCR and machine learning, that are enabling smarter decision-making in insurance. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 331 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

The dreaded esophageal injury.  Do you still have nightmares about mock oral board scenarios torturing you with the ins and outs of how to manage traumatic esophageal injury?  Think you remember all the nuances?  Whether you do or you don't, this episode should serve as a good refresher for all levels while offering some pearls for management of this tricky scenario. Hosts: - Michael Cobler-Lichter, MD, PGY4/R2: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @mdcobler (X/twitter) - Dylan Tanzer, MD, 2nd-year Trauma/Surgical Critical Care Fellow University of Miami/Jackson Memorial Hospital/Ryder Trauma Center - Eugenia Kwon, MD, Trauma/Surgical Critical Care Attending: Loma Linda University Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center Trauma/CC Fellowship - Jonathan Meizoso, MD, MSPH Assistant Professor of Surgery, 5 years in practice University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @jpmeizoso (twitter) Learning Objectives: - Describe the diagnostic workup of a suspected traumatic esophageal injury - Identify when someone with suspected esophageal injury needs immediate surgical management - Describe appropriate surgical techniques for repair of both cervical and thoracic esophageal injuries Quick Hits: 1.     Don't forget the primary survey.  Unstable patients should be in the OR, as should patients with hard signs of vascular or aerodigestive injury 2.     If there is concern for esophageal injury but no immediate indication for the OR, this should be further investigated with CTA of the affected area.  Clinical exam has poor sensitivity. 3.     The esophagus should be primarily repaired if the defect is able to come together without tension after debridement.  Don't forget a well-vascularized buttress 4.     If you cannot perform a primary repair, your procedure of choice should be lateral esophagostomy with feeding jejunostomy and gastrostomy for decompression.  Repair over T-tube can be considered for injuries with small amounts of tissue loss References 1.     Biffl WL, Moore EE, Feliciano DV, Albrecht RA, Croce M, Karmy-Jones R, et al. Western Trauma Association Critical Decisions in Trauma: Diagnosis and Management of Esophageal Injuries. J Trauma Acute Care Surg 2015;79(6):1089-95. https://pubmed.ncbi.nlm.nih.gov/26680145/ 2.     Sperry JL, Moore EE, Coimbra R, Croce M, Davis JW, Karmy-Jones R, et al. Western Trauma Association Critical Decisions in Trauma: Penetrating Neck Trauma. J Trauma Acute Care Surg 2013;75(6):936-40. https://pubmed.ncbi.nlm.nih.gov/24256663/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

How can impartial valuations drive transparency and trust in insurance? Kroll's platform provides property valuations through data-driven insights that benefit insurers, brokers and property owners alike. Matthew Grant sits down with Kiran Aulakh, Kroll's VP of Fixed Asset Advisory, to explore how Kroll's platform combines technology and real-time data to assess underinsurance and overinsurance risks across vast property portfolios.  Kiran shares her insights on the value of green valuations, and the importance of impartial assessments, which Kroll provides through both an API and a standalone platform for seamless integration into clients' ecosystems. Key talking points: The role of impartial valuations in improving insurer-client trust How Kroll's platform combines technology with in-person expertise Reducing claims friction by accurately assessing property insurance needs Using valuation data to better negotiate policy terms for clients Kroll's partnership with WTW and global insurers to streamline valuation assessments Real-time data updates and third-party integration for accurate market responses Green valuations and the impact of ESG on future property valuation trends Aulakh's thoughts on data scalability and how it supports insurer-broker collaboration If you like what you're hearing, please leave us a review on whichever platform you use or contact Kiran Aulakh or Matthew Grant on LinkedIn. Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe the role of impartial valuations in managing underinsurance and overinsurance risks. Define the impact of valuation accuracy on insurance policy terms and claims outcomes. Measure the importance of transparent valuations in fostering stronger insurer-client relationships. If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 327 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

How do you shed light on ‘dark shipping activity'? S&P Global Market Intelligence aims to support insurers throughout the entire insurance value chain by providing critical data and insights. Matthew Grant is joined by George Devereese, who monitors and tracks shipping around the world to screen them against various forms of liabilities. This data is passed onto markets such as the insurance world, to build a better and fuller picture for the insurance contract.  A key aspect of this process involves identifying and understanding the risks associated with illicit or ‘dark' shipping activities. Key talking points include: How are the analytics provided helping insurers? Why all navigation is a timestamp. What is AIS and how can it help an insurer understand a ship's history? Understanding a ship's risk - from tracking to insurance contracts Driving frigates and hunting pirates - George's time in the Navy On becoming ‘dark' - are there exemptions to turning off AIS? Collaborating with Concirrus  Cross pollination of data - understanding a bigger and better picture for underwriting risk New launches in S&P's Global Market Intelligence portal and looking ahead to the future If you like what you're hearing, please leave us a review on whichever platform you use or contact Matthew Grant on LinkedIn. Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how data on a ship's movement can better inform an underwriter's decision Explain what an AIS is, why this can be manipulated by some vessels, and how this affects the underwriter Define dark shipping activity and why it is important to understand its implications in insurance If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 326 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

Ben Turner joked that he'd “be a rich man for every pound [he] had somebody asking” what Salesforce has to offer the insurance world.  Robin Merttens is joined this week by Ben Turner and Tom Swire at Salesforce, who touch on their journey to joining the company, the trouble with legacy systems and the exciting prospects for the future including an agency management system to be launched in 2025. If you enjoyed this conversation and would like to hear more, our October evening event hosted in collaboration with Salesforce and Azur Technology was recorded. The videos will be available on our website soon. Key talking points include: On working as an underwriter or in insurance market standards to joining Salesforce - the journey Salesforce's place in insurance The importance of the workbench Case studies from the front line - N2G and Crux Underwriting The Salesforce approach to AI - creating your own bot Looking ahead to the future - all the exciting launches A match made in heaven - working with ecosystems and partners Transformation - making the unknown and scary just that tiny bit more familiar If you like what you're hearing, please leave us a review on whichever platform you use or contact Matthew Grant on LinkedIn. Sign up to the InsTech newsletter for a fresh view on the world every Wednesday morning. Continuing Professional Development This InsTech Podcast Episode is accredited by the Chartered Insurance Institute (CII). By listening, you can claim up to 0.5 hours towards your CPD scheme. By the end of this podcast, you should be able to meet the following Learning Objectives: Describe how Salesforce operates in the insurance sector and the benefit of pre-built templates  Specify how a CRM system can be a strong foundation for building an underwriting workbench Explain how ecosystems work and how do you pick a successful partner If your organisation is a member of InsTech and you would like to receive a quarterly summary of the CPD hours you have earned, visit the Episode 325 page of the InsTech website or email cpd@instech.co to let us know you have listened to this podcast. To help us measure the impact of the learning, we would be grateful if you would take a minute to complete a quick feedback survey.

In this World Shared Practice Forum Podcast, Drs. Adrienne Randolph and Aaron Bodansky explore the groundbreaking research findings that uncover the pathophysiological mechanism behind multisystem inflammatory syndrome in children (MIS-C). These findings shed light on the characteristic immune response of patients who develop MIS-C, and provide insight into the development of post-infectious auto-immune disease phenotypes. LEARNING OBJECTIVES - Describe the pathophysiology of MIS-C, including the clinical features and molecular immune response - Describe the immune dysregulation that results in MIS-C, including the role of autoantibodies and T-cell responses - Identify the potential connections between SARS-CoV-2 infection and the development of autoimmune responses - Recognize the implications of the study findings for other related conditions such as long COVID and sepsis AUTHORS Adrienne Randolph, MD, MSc Senior Associate in Critical Care Medicine, Department of Anesthesiology, Critical Care and Pain Medicine Boston Children's Hospital Professor of Anaesthesia and Pediatrics Harvard Medical School Aaron Bodansky, MD Assistant Professor Pediatric Critical Care University of California, San Francisco School of Medicine DATES Initial publication: September 24, 2024. ARTICLES REFERENCED Bodansky A, Mettelman RC, Sabatino JJ Jr, et al. Molecular mimicry in multisystem inflammatory syndrome in children. Nature. 2024;632(8025):622-629. doi:10.1038/s41586-024-07722-4. Please visit: http://www.openpediatrics.org OPENPediatrics™ is an interactive digital learning platform for healthcare clinicians sponsored by Boston Children's Hospital and in collaboration with the World Federation of Pediatric Intensive and Critical Care Societies. It is designed to promote the exchange of knowledge between healthcare providers around the world caring for critically ill children in all resource settings. The content includes internationally recognized experts teaching the full range of topics on the care of critically ill children. All content is peer-reviewed and open access-and thus at no expense to the user.For further information on how to enroll, please email: openpediatrics@childrens.harvard.edu CITATION Randolph AG, Bodansky A, Burns JP. Unveiling MIS-C's Immune Response: Molecular Mimicry. 09/2024. OPENPediatrics. https://soundcloud.com/openpediatrics/unveiling-mis-cs-immune-response-molecular-mimicry-by-a-randolph-and-a-bodansky-openpediatrics

VTE prophylaxis is more than just some squeezy leg socks and a one-size fits all dose of enoxaparin!  Ever wonder how VTE prophylaxis is similar to constipation?  Have you or a loved one been hurt by a hospital administrator telling you that VTE is a never event?  Come with us, and our special guest Dr. Bryan Cotton, on this journey to the frontier of research attempting to debunk this myth and improve patient care by reducing VTE rates in trauma patients.   Hosts: - Michael Cobler-Lichter, MD, PGY4/R2: University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @mdcobler (X/twitter) - Eva Urrechaga, MD, PGY-8, Vascular Surgery Fellow University of Pennsylvania Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center General Surgery Residency @urrechisme (X/twitter) - Eugenia Kwon, MD, Trauma/Surgical Critical Care Attending: Loma Linda University Recent graduate of University of Miami/Jackson Memorial Hospital/Ryder Trauma Center Trauma/CC Fellowship - Brandon Parker, DO, Assistant Professor of Surgery, 5 years in practice University of Miami/Jackson Memorial Hospital/Ryder Trauma Center @BrandonParkerDO (X/twitter) - Bryan Cotton, MD, MPH, FACS, Professor of Surgery, 20 years in practice  University of Texas Health Science Center at Houston/Red Duke Trauma Institute at Memorial Herman Hospital @bryanacotton1 (X/twitter) Learning Objectives: - Describe the rationale for the addition of aspirin to chemoprophylactic regimens for VTE -  Identify appropriate screening systems for trauma patients at high risk for VTE -  Describe the rationale for monitoring anti factor Xa levels in the trauma population receiving VTE chemoprophylaxis - List the major conclusions of the two studies discussed regarding the addition of aspirin to VTE chemoprophylaxis regimens in trauma patients, and the change in antithrombin activity levels over time in relation to enoxaparin responsiveness in polytrauma patients Quick Hits: 1.     On adjusted analysis, the standard VTE PPX plus aspirin group had a lower OR of developing VTE, though limitations of this study highlight need for future prospective work 2.     Trauma patients often suffer from decreased activity of antithrombin 3, which may mediate the relatively higher rates of VTE in this population. 3.     Trauma patients who went on to develop VTE were more likely to not achieve satisfactory anti Xa levels, with a VTE rate of 30% in the never-responder group, the group for which Xa levels were never higher than 0.2 4.     Ex vivo supplementation of antithrombin seems to improve enoxaparin responsiveness.  Remember, enoxaparin and heparin are HELPING AT3, not the other way around References 1.     Lammers D, Scerbo M, Davidson A, et al. Addition of aspirin to venous thromboembolism chemoprophylaxis safely decreases venous thromboembolism rates in trauma patients. Trauma Surg Acute Care Open. 2023;8(1):e001140. doi:10.1136/tsaco-2023-001140 https://pubmed.ncbi.nlm.nih.gov/37936904/ 2.     Vincent LE, Talanker MM, Butler DD, et al. Association of Changes in Antithrombin Activity Over Time With Responsiveness to Enoxaparin Prophylaxis and Risk of Trauma-Related Venous Thromboembolism. JAMA Surg. 2022;157(8):713-721. doi:10.1001/jamasurg.2022.2214 https://pubmed.ncbi.nlm.nih.gov/35731524/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

In this episode our team dives into the diagnosis, workup and management of malignant pleural mesothelioma. Listen as we debate the pros and cons of surgical management of this disease with extrapleural pneumonectomy versus pleural decortication and discuss the nuances of choosing the right approach for the right patient. Learning Objectives - Describe the workup and staging of a patient with malignant pleural mesothelioma - List the subtypes of malignant pleural mesothelioma, characteristics of resectable disease, and patient factors which impact surgical candidacy  - Describe the approach to an extrapleural pneumonectomy and pleural decortication - Analyze which surgical approach is best for various subsets of patients - Describe the adjuvant treatment for malignant pleural mesothelioma Hosts Kelly Daus MD, Adam Bograd MD, Peter White MD, Brian Louie MD Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out more recent episodes: https://app.behindtheknife.org/listen

Eat when you can, sleep when you can, and don't F with the pancreas!  What happens when that third rule goes wrong, and why do people say pancreas injuries are like eating crawfish?  Whether you love the pancreas or just the mention of the P-word strikes fear in your heart, or if you just want the answer to the aforementioned questions, join Drs. Cobler-Lichter, Kwon, and Meizoso, as they guide you through all this and more!  Hosts: - Michael Cobler-Lichter, MD, PGY3, University of Miami/Jackson Memorial Hospital/Ryder Trauma Center, @mdcobler (twitter) - Eugenia Kwon, MD, Trauma/Surgical Critical Care Fellow, University of Miami/Jackson Memorial Hospital/Ryder Trauma Center -Jonathan Meizoso, MD, MSPH Assistant Professor of Surgery, 4 years in practice, University of Miami/Jackson Memorial Hospital/Ryder Trauma Center, @jpmeizoso (twitter) Learning Objectives: - Describe the AAST grading system for pancreatic injuries - Come up with a treatment plan for each grade of pancreatic injury - Identify commonly associated injuries with pancreatic trauma -  List potential complications of pancreatic trauma and/or surgery Quick Hits: 1. Pancreas injuries do not all require a trip to the operating room. Low grade injuries should be managed with a trial of nonoperative management if there are no other operative indications 2. CT is the best initial imaging modality, although it has low sensitivity. If there is high concern for a pancreas injury based on mechanism or associated injuries, further investigation is required. 3. Pancreas injuries are like crawfish: suck the head and eat the tail. 4. Injuries to the left of the SMV can generally be treated with distal pancreatectomy and splenectomy, whereas injuries to the right of the SMV are usually drained. 5. Its important to identify and address any concomitant injuries, with duodenal injuries being the most common in higher grade injuries. 6. In the case of the dreaded grade 5 injury, the safe answer is to come back and do your reconstruction at a later time. References 1.     https://www.westerntrauma.org/western-trauma-association-algorithms/management-of-pancreatic-injuries/ 2.     Bassi, Claudio et al. The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery, Volume 161, Issue 3, 584 – 591 https://pubmed.ncbi.nlm.nih.gov/28040257/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen